JP4094710B2 - 新規なカンプトテシン誘導体 - Google Patents

新規なカンプトテシン誘導体 Download PDF

Info

Publication number
JP4094710B2
JP4094710B2 JP31918297A JP31918297A JP4094710B2 JP 4094710 B2 JP4094710 B2 JP 4094710B2 JP 31918297 A JP31918297 A JP 31918297A JP 31918297 A JP31918297 A JP 31918297A JP 4094710 B2 JP4094710 B2 JP 4094710B2
Authority
JP
Japan
Prior art keywords
group
och
compound
dimethylamino
ethylamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP31918297A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11140085A5 (enExample
JPH11140085A (ja
Inventor
貴徳 小川
▲隆▼ 八重樫
誠吾 沢田
富雄 古田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP31918297A priority Critical patent/JP4094710B2/ja
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to EP98951712A priority patent/EP1029863B1/en
Priority to DE69814667T priority patent/DE69814667T2/de
Priority to AU97619/98A priority patent/AU738823B2/en
Priority to CA002309196A priority patent/CA2309196C/en
Priority to PT98951712T priority patent/PT1029863E/pt
Priority to PCT/JP1998/005000 priority patent/WO1999024430A1/ja
Priority to KR1020007004645A priority patent/KR100563210B1/ko
Priority to US09/530,828 priority patent/US6310210B1/en
Priority to BR9813972-0A priority patent/BR9813972A/pt
Priority to EA200000491A priority patent/EA002211B1/ru
Priority to CN98810870A priority patent/CN1114605C/zh
Priority to ES98951712T priority patent/ES2193574T3/es
Priority to AT98951712T priority patent/ATE240330T1/de
Priority to DK98951712T priority patent/DK1029863T3/da
Publication of JPH11140085A publication Critical patent/JPH11140085A/ja
Publication of JPH11140085A5 publication Critical patent/JPH11140085A5/ja
Application granted granted Critical
Publication of JP4094710B2 publication Critical patent/JP4094710B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
JP31918297A 1997-11-06 1997-11-06 新規なカンプトテシン誘導体 Expired - Fee Related JP4094710B2 (ja)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP31918297A JP4094710B2 (ja) 1997-11-06 1997-11-06 新規なカンプトテシン誘導体
EA200000491A EA002211B1 (ru) 1997-11-06 1998-11-06 Новые производные камптотецина
AU97619/98A AU738823B2 (en) 1997-11-06 1998-11-06 New camptothecin derivatives
CA002309196A CA2309196C (en) 1997-11-06 1998-11-06 Novel camptothecin derivatives
PT98951712T PT1029863E (pt) 1997-11-06 1998-11-06 Derivados de camptotecina
PCT/JP1998/005000 WO1999024430A1 (en) 1997-11-06 1998-11-06 Novel camptothecin derivatives
KR1020007004645A KR100563210B1 (ko) 1997-11-06 1998-11-06 신규한 캄프토테신 유도체
US09/530,828 US6310210B1 (en) 1997-11-06 1998-11-06 Camptothecin derivatives
EP98951712A EP1029863B1 (en) 1997-11-06 1998-11-06 Camptothecin derivatives
DE69814667T DE69814667T2 (de) 1997-11-06 1998-11-06 Camptothecin-derivate
CN98810870A CN1114605C (zh) 1997-11-06 1998-11-06 新型喜树碱衍生物
ES98951712T ES2193574T3 (es) 1997-11-06 1998-11-06 Deriados de camptotecina.
AT98951712T ATE240330T1 (de) 1997-11-06 1998-11-06 Camptothecin-derivate
DK98951712T DK1029863T3 (da) 1997-11-06 1998-11-06 Camptothecinderivater
BR9813972-0A BR9813972A (pt) 1997-11-06 1998-11-06 Derivados de camptotecina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31918297A JP4094710B2 (ja) 1997-11-06 1997-11-06 新規なカンプトテシン誘導体

Publications (3)

Publication Number Publication Date
JPH11140085A JPH11140085A (ja) 1999-05-25
JPH11140085A5 JPH11140085A5 (enExample) 2005-01-06
JP4094710B2 true JP4094710B2 (ja) 2008-06-04

Family

ID=18107341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31918297A Expired - Fee Related JP4094710B2 (ja) 1997-11-06 1997-11-06 新規なカンプトテシン誘導体

Country Status (15)

Country Link
US (1) US6310210B1 (enExample)
EP (1) EP1029863B1 (enExample)
JP (1) JP4094710B2 (enExample)
KR (1) KR100563210B1 (enExample)
CN (1) CN1114605C (enExample)
AT (1) ATE240330T1 (enExample)
AU (1) AU738823B2 (enExample)
BR (1) BR9813972A (enExample)
CA (1) CA2309196C (enExample)
DE (1) DE69814667T2 (enExample)
DK (1) DK1029863T3 (enExample)
EA (1) EA002211B1 (enExample)
ES (1) ES2193574T3 (enExample)
PT (1) PT1029863E (enExample)
WO (1) WO1999024430A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR027687A1 (es) 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
HUP0401912A3 (en) 2001-09-25 2007-02-28 Reddys Lab Ltd Dr Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them
WO2003033525A1 (en) * 2001-10-12 2003-04-24 Debio Recherche Pharmacuetique S.A. Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
US6608076B1 (en) 2002-05-16 2003-08-19 Enzon, Inc. Camptothecin derivatives and polymeric conjugates thereof
AU2003288467A1 (en) * 2002-12-13 2004-07-09 Immunomedics, Inc. Immunoconjugates with an intracellularly-cleavable linkage
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
DE602005024923D1 (de) * 2004-02-13 2011-01-05 Yakult Honsha Kk Wässrige lösung mit einem camptothecin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS5839684A (ja) 1981-09-04 1983-03-08 Yakult Honsha Co Ltd １０−置換カンプテシン誘導体の製造法
JPS58134095A (ja) 1982-02-05 1983-08-10 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
JPS5951287A (ja) 1982-09-17 1984-03-24 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
JPS5951289A (ja) 1982-09-17 1984-03-24 Yakult Honsha Co Ltd 新規な９−置換−カンプトテシン誘導体
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5049668A (en) 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
US5122606A (en) 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
JP2540357B2 (ja) 1987-06-24 1996-10-02 第一製薬株式会社 六環性化合物
US4939255A (en) 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
JP2538792B2 (ja) 1987-06-25 1996-10-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
CA1332413C (en) * 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPH0615547B2 (ja) 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
WO1991004260A2 (en) 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
US5162532A (en) 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
JPH0873461A (ja) * 1994-09-06 1996-03-19 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤

Also Published As

Publication number Publication date
AU9761998A (en) 1999-05-31
DE69814667D1 (en) 2003-06-18
EP1029863A4 (en) 2001-05-02
BR9813972A (pt) 2000-09-26
KR20010031595A (ko) 2001-04-16
EP1029863B1 (en) 2003-05-14
CN1278261A (zh) 2000-12-27
ES2193574T3 (es) 2003-11-01
PT1029863E (pt) 2003-09-30
DK1029863T3 (da) 2003-08-11
US6310210B1 (en) 2001-10-30
AU738823B2 (en) 2001-09-27
JPH11140085A (ja) 1999-05-25
EA002211B1 (ru) 2002-02-28
EP1029863A1 (en) 2000-08-23
ATE240330T1 (de) 2003-05-15
CA2309196C (en) 2007-09-11
KR100563210B1 (ko) 2006-03-22
EA200000491A1 (ru) 2000-10-30
CN1114605C (zh) 2003-07-16
WO1999024430A1 (en) 1999-05-20
DE69814667T2 (de) 2004-04-08
CA2309196A1 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
KR100191193B1 (ko) 6환 화합물
EP0088642A2 (en) New camptothecin derivatives and process for their preparation
JP4094710B2 (ja) 新規なカンプトテシン誘導体
Rivalle et al. Antitumor amino-substituted pyrido [3', 4': 4, 5] pyrrolo [2, 3-g] isoquinolines and pyrido [4, 3-b] carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications
US6268375B1 (en) 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
JPH05247055A (ja) スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤
US6723729B2 (en) Compounds useful in preparing camptothecin derivatives
EP0028936B1 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
US5281708A (en) 9-Substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors of PNP
CA2271940C (en) Novel phenanthridinium derivatives
HUT71240A (en) Process for the preparation of 9-amino camptothecin
JPS62195384A (ja) 新規なカンプトテシン誘導体
JPH0121828B2 (enExample)
KR20010029811A (ko) 7-옥소-2,3,7,14-테트라히드로-1Ｈ-벤조[ｂ]피라노[3,2-ｈ]아크리딘 카르복실레이트의 화합물, 이것의 제조 방법 및이를 함유하는 약제 조성물
Mimura et al. An efficient synthesis of a new class of DNA intercalating antitumor 7, 10-dihydroxy-6H-pyrazolo [4, 5, 1-de] acridin-6-ones
JPH069642A (ja) ４−デソキシ−４−エピポドフィロトキシン誘導体及びその塩
JP3527255B2 (ja) ６−ｎ−置換アミノピコリン酸誘導体及びその製造法
JP3154783B2 (ja) ２’−（ジエチルアミノ）リフアマイシンｐ（ｐ／ｄｅａ）の新規製造法
JPH05247056A (ja) インドロカルバゾール誘導体
US20050197355A1 (en) Compounds useful in preparing camptothecin derivatives
JPH06228139A (ja) 三環結合ヒドロキシグアニジン、その製造法及びそれを含む抗癌組成物
JPS6197285A (ja) ピラゾロピリジン化合物
JPH0551384A (ja) Ｄｃ−８９誘導体
PL185427B1 (pl) Sposób wytwarzania nowych pochodnych metylosulfonylowych układów biheteroaromatycznych
WO1997046559A1 (en) Process for preparing 9-hydroxyellipticine

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040203

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040203

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071213

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080212

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080306

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110314

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110314

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120314

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120314

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130314

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140314

Year of fee payment: 6

LAPS Cancellation because of no payment of annual fees